As President and CEO of the Massachusetts Biotechnology Council, Bob’s mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Over the last decade, Bob has truly become a champion for patients by ensuring innovative companies have the best environment possible to research, develop, and commercialize breakthrough therapies and cures for people around the world who need and deserve them. Bob has spent his career in both the public and private sectors. Before joining MassBio, he served as the Undersecretary of Economic Development within Governor Deval Patrick's administration, where he prioritized both healthcare and economic development issues and was a strong advocate for the life sciences industry in Massachusetts. Prior to that, he was elected as State Representative to the 11th Norfolk district for three terms. Bob has also held senior executive positions in the environmental services, capital management and venture capital industries. He brings passion and energy to all of his endeavors.

As Head of the U.S. Plasma Derived Therapies Business Unit at Takeda, Brandon is responsible for ensuring that the company’s critical, life-saving plasma derived medicines are available for the thousands of people with rare and complex diseases who rely on them. In his role, he oversees the business performance, marketing and strategy for the business unit’s multiple brands while leading and coaching his team. Brandon was previously the Head of the U.S. Immunology/Albumin Franchise at Takeda before assuming his current position. Prior to Takeda’s acquisition of Shire in January 2019, Brandon served as Vice President of Sales for U.S. Immunology and later as Vice President of U.S. Immunology Institutional Sales & Marketing at Shire. During this time, he played an integral role leading the sales and marketing teams through organizational, market and leadership changes, while navigating a complex supply shortage environment. Prior to his experience with Shire and Takeda, Brandon held a number of positions with some of the leading pharmaceutical companies, including Baxalta, Baxter, and Eli Lilly and Company. He holds a BA in Business Administration from Hanover College and an MBA from the Massachusetts Institute of Technology Sloan School of Management.